Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis

References

• BrayF, FerlayJ, SoerjomataramI, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• WuJ, ChengG, ZhangC, et al. Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis. Onco Targets Ther. 2017;10:1843–1852. doi:10.2147/OTT.S12992828392705
   PubMed Web of Science ®Google Scholar
• GalskyMD, VogelzangNJ. Docetaxel-based combination therapy for castration-resistant prostate cancer. Ann Oncol. 2010;21(11):2135–2144. doi:10.1093/annonc/mdq05020351071
   PubMed Web of Science ®Google Scholar
• SekinoY, OueN, KoikeY, et al. KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer. J Clin Med. 2019;8(2):225. doi:10.3390/jcm8020225
   Web of Science ®Google Scholar
• CocucciE, MeldolesiJ. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25(6):364–372. doi:10.1016/j.tcb.2015.01.00425683921
   PubMed Web of Science ®Google Scholar
• BeiY, DasS, RodosthenousRS, et al. Extracellular vesicles in cardiovascular theranostics. Theranostics. 2017;7(17):4168–4182. doi:10.7150/thno.2127429158817
   PubMed Web of Science ®Google Scholar
• TakahashiK, YanIK, KogureT, et al. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio. 2014;4(1):458–467. doi:10.1016/j.fob.2014.04.007
   PubMed Web of Science ®Google Scholar
• VlassovAV, MagdalenoS, SetterquistR, et al. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 2012;1820(7):940–948. doi:10.1016/j.bbagen.2012.03.01722503788
   PubMed Web of Science ®Google Scholar
• GeR, TanE, Sharghi-NaminiS, et al. Exosomes in cancer microenvironment and beyond: have we overlooked these extracellular messengers? Cancer Microenviron. 2012;5(3):323–332. doi:10.1007/s12307-012-0110-222585423
   PubMedGoogle Scholar
• CuiJ, WangH, ZhangX, et al. Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B. Aging (Albany NY). 2020;12(8):6756–6773. doi:10.18632/aging.10303632310826
   PubMedGoogle Scholar
• MallaB, ZauggK, VassellaE, et al. Exosomes and exosomal microRNAs in prostate cancer radiation therapy. Int J Radiat Oncol Biol Phys. 2017;98(5):982–995. doi:10.1016/j.ijrobp.2017.03.03128721912
   PubMed Web of Science ®Google Scholar
• MemczakS, JensM, ElefsiniotiA, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333. doi:10.1038/nature1192823446348
   PubMed Web of Science ®Google Scholar
• ChenLL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016;17(4):205–211. doi:10.1038/nrm.2015.3226908011
   PubMed Web of Science ®Google Scholar
• ArnaizE, SoleC, ManterolaL, et al. CircRNAs and cancer: biomarkers and master regulators. Semin Cancer Biol. 2019;58:90–99. doi:10.1016/j.semcancer.2018.12.00230550956
   PubMed Web of Science ®Google Scholar
• VoJN, CieslikM, ZhangY, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869–881.e813. doi:10.1016/j.cell.2018.12.02130735636
   PubMed Web of Science ®Google Scholar
• HongX, LiuN, LiangY, et al. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1. Mol Cancer. 2020;19(1):33. doi:10.1186/s12943-020-01149-x32061262
   PubMed Web of Science ®Google Scholar
• GaoY, LiuJ, HuanJ, et al. Downregulation of circular RNA hsa_circ_0000735 boosts prostate cancer sensitivity to docetaxel via sponging miR-7. Cancer Cell Int. 2020;20(1):334. doi:10.1186/s12935-020-01421-632714093
   PubMed Web of Science ®Google Scholar
• LiY, ZhengQ, BaoC, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981–984. doi:10.1038/cr.2015.8226138677
   PubMed Web of Science ®Google Scholar
• WangY, LiuJ, MaJ, et al. Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer. 2019;18(1):116. doi:10.1186/s12943-019-1041-z31277663
   PubMed Web of Science ®Google Scholar
• FengY, YangY, ZhaoX, et al. Circular RNA circ0005276 promotes the proliferation and migration of prostate cancer cells by interacting with FUS to transcriptionally activate XIAP. Cell Death Dis. 2019;10(11):792. doi:10.1038/s41419-019-2028-931624242
   PubMed Web of Science ®Google Scholar
• BachDH, LeeSK, SoodAK. Circular RNAs in Cancer. Mol Ther Nucleic Acids. 2019;16:118–129. doi:10.1016/j.omtn.2019.02.00530861414
   PubMedGoogle Scholar
• HouXS, HanCQ, ZhangW. MiR-1182 inhibited metastasis and proliferation of ovarian cancer by targeting hTERT. Eur Rev Med Pharmacol Sci. 2018;22(6):1622–1628. doi:10.26355/eurrev_201803_1456929630105
   PubMed Web of Science ®Google Scholar
• XiaoJ, YuH, MaZ. LINC00339 promotes growth and invasiveness of hepatocellular carcinoma by the miR-1182/SKA1 pathway. Onco Targets Ther. 2019;12:4481–4488. doi:10.2147/OTT.S20739731239716
   PubMed Web of Science ®Google Scholar
• HuangC, DengH, WangY, et al. Circular RNA circABCC4 as the ceRNA of miR-1182 facilitates prostate cancer progression by promoting FOXP4 expression. J Cell Mol Med. 2019;23(9):6112–6119. doi:10.1111/jcmm.1447731270953
   PubMed Web of Science ®Google Scholar
• ByrneJA, BalleineRL, Schoenberg FejzoM, et al. Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer. Int J Cancer. 2005;117(6):1049–1054. doi:10.1002/ijc.2125015986428
   PubMed Web of Science ®Google Scholar
• DasariC, YaghnamDP, WaltherR, et al. Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells. Tumour Biol. 2017;39(5):1010428317698382. doi:10.1177/101042831769838228466782
   PubMedGoogle Scholar
• SuQ, LvX. Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis. Genomics. 2020;112(2):1680–1685. doi:10.1016/j.ygeno.2019.10.00631626900
   PubMed Web of Science ®Google Scholar
• SchattenH. Brief overview of prostate cancer statistics, grading, diagnosis and treatment strategies. Adv Exp Med Biol. 2018;1095:1–14.30229546
   PubMed Web of Science ®Google Scholar
• ShiX, WangB, FengX, et al. circRNAs and exosomes: a mysterious frontier for human cancer. Mol Ther Nucleic Acids. 2020;19:384–392. doi:10.1016/j.omtn.2019.11.02331887549
   PubMedGoogle Scholar
• WangX, ZhangH, YangH, et al. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Mol Oncol. 2020;14(3):539–555. doi:10.1002/1878-0261.1262931901148
   PubMed Web of Science ®Google Scholar
• DuijveszD, LuiderT, BangmaCH, et al. Exosomes as biomarker treasure chests for prostate cancer. Eur Urol. 2011;59(5):823–831. doi:10.1016/j.eururo.2010.12.03121196075
   PubMed Web of Science ®Google Scholar
• LiW, LiC, ZhouT, et al. Role of exosomal proteins in cancer diagnosis. Mol Cancer. 2017;16(1):145. doi:10.1186/s12943-017-0706-828851367
   PubMed Web of Science ®Google Scholar
• HanC, WangS, WangH, et al. Exosomal circ-HIPK3 facilitates tumor progression and temozolomide resistance by regulating miR-421/ZIC5 axis in glioma. Cancer Biother Radiopharm. 2020.
   Web of Science ®Google Scholar
• HuK, LiuX, LiY, et al. Exosomes mediated transfer of circ_UBE2D2 enhances the resistance of breast cancer to tamoxifen by binding to miR-200a-3p. Med Sci Monit. 2020;26:e922253. doi:10.12659/MSM.92225332756532
   PubMed Web of Science ®Google Scholar
• TutarY. miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol. 2014;15(5):429. doi:10.2174/13892010150514082816133525189575
   PubMed Web of Science ®Google Scholar
• MishraS, YadavT, RaniV. Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol. 2016;98:12–23. doi:10.1016/j.critrevonc.2015.10.00326481951
   PubMed Web of Science ®Google Scholar
• ZongZH, DuYP, GuanX, et al. CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182. J Exp Clin Cancer Res. 2019;38(1):437. doi:10.1186/s13046-019-1437-z31666098
   PubMed Web of Science ®Google Scholar
• ZhangD, XiaoYF, ZhangJW, et al. miR-1182 attenuates gastric cancer proliferation and metastasis by targeting the open reading frame of hTERT. Cancer Lett. 2015;360(2):151–159. doi:10.1016/j.canlet.2015.01.04425662441
   PubMed Web of Science ®Google Scholar
• ZhouJ, DaiW, SongJ. miR-1182 inhibits growth and mediates the chemosensitivity of bladder cancer by targeting hTERT. Biochem Biophys Res Commun. 2016;470(2):445–452. doi:10.1016/j.bbrc.2016.01.01426772886
   PubMed Web of Science ®Google Scholar
• LiJ, LiY, LiuH, et al. The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis. PLoS One. 2017;12(5):e0178515. doi:10.1371/journal.pone.017851528562687
   PubMed Web of Science ®Google Scholar
• UmmanniR, TellerS, JunkerH, et al. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells. Febs j. 2008;275(22):5703–5713. doi:10.1111/j.1742-4658.2008.06697.x18959755
   PubMed Web of Science ®Google Scholar
• ZengJ, LiuW, FanYZ, et al. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy. Theranostics. 2018;8(1):109–123. doi:10.7150/thno.2035629290796
   PubMed Web of Science ®Google Scholar